Corporations that develop, manufacture or contract to manufacture inhaled or intranasal drug products are eligible for membership in IPAC-RS. A corporation is eligible for participation in IPAC-RS initiatives as an associate member if it develops or manufactures components and/or devices for orally inhaled and nasal drug products (OINDP) or provides scientific or technical services relating to development and manufacture of OINDP. Our current members include:
- Boehringer Ingelheim
- Lupin Pharmaceuticals, Inc.
- Merck & Co., Inc.
- Vectura Ltd.
In addition, the following suppliers of device components for orally inhaled and nasal drug products participate are associate members of IPAC-RS: